Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort study

Table 3 Risk estimates for adverse pregnancy and neonatal outcomes according to COVID-19 exposure (n = 223)

Pregnancy outcomes	COVID-19 positive n = 21	COVID-19 negative n = 202	p-value
Pregnancy outcome
Abortion	1 (4.8%)	0 (0.0%)	0.08
Foetal Death	2 (9.5%)	4 (2.0%)	0.09
Live birth	18 (85.7%)	198 (98.0%)	Ref.
Preterm birth^a	3 (15.0%)	49 (25.4%)	0.42
Pre-eclampsia	1 (4.8%)	52 (25.7%)	0.03
Mode of delivery
Vaginal birth	18 (85.7%)	154 (76.2%)	Ref.
Elective C-section	2 (9.5%)	21 (10.4%)	1
Intrapartum C-section	1 (4.8%)	27 (13.4%)	0.48
Apgar < 7 at 1st minute^b	1 (5.9%)	36 (19.1%)	0.31
Apgar < 7 at 5th minute^b	0 (0.0%)	14 (7.4%)	–
Neonatal respiratory distress^c	0 (0.0%)	25 (14.7%)	–
Neonatal mechanical ventilation^d	0 (0.0%)	8 (4.7%)	–
NICU admission^e	2 (12.5%)	36 (20.6%)	0.74
Any neonatal morbidity	2 (9.5%)	43 (21.3%)	0.26
Congenital anomaly	0 (0.0%)	2 (1.12%)	–
Neonatal death	0 (0.0%)	5 (2.9%)	–
Any APO/WHO*	7 (33.3%)	67 (33.2%)	0.98
Any gestational intercurrence**	5 (23.8%)	48 (23.8%)	0.99

Missing information ^a10, ^b18, ^c37, ^d35, ^e25
*APO (any adverse pregnancy outcome): NICU admission, preterm birth, foetal death, neonatal death, miscarriage/abortion
**Hyperemesis, Foetal growth restriction, haemorrhage during pregnancy, threatened preterm labour

ISSN: 1742-4755